DCA
ABBV icon

DSG Capital Advisors’s AbbVie ABBV Stock Holding History

DSG Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.2M Sell
42,309
-2,998
-7% -$665K 1.47% 23
2025
Q4 		$9.82M Buy
45,307
+5,090
+13% +$1.16M 1.5% 21
2025
Q3 		$9.31M Buy
40,217
+22,700
+130% +$4.62M 1.48% 22
2025
Q2 		$3.25M Sell
17,517
-294
-2% -$54.6K 0.58% 40
2025
Q1 		$3.73M Sell
17,811
-270
-1% -$52.5K 0.75% 36
2024
Q4 		$3.21M Buy
+18,081
New +$3.32M 0.58% 44

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DSG Capital Advisors's ABBV Position: Q1 2026 in Review

DSG Capital Advisors reduced its AbbVie (ABBV) stake by 6.6% in Q1 2026, selling an estimated $665K and leaving 42,309 shares worth $9.2M. The position accounts for 1.47% of the portfolio, ranked #23.

DSG Capital Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.82M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • DSG Capital Advisors held 42,309 shares of AbbVie worth $9.2M as of Q1 2026.
  • DSG Capital Advisors sold 2,998 AbbVie shares in Q1 2026, an estimated $665K.
  • AbbVie made up 1.47% of DSG Capital Advisors's portfolio in Q1 2026, its #23 holding.
  • DSG Capital Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • DSG Capital Advisors's AbbVie position peaked at $9.82M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DSG Capital Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.